Speaker illustration

Miss Elina Rautio

Karolinska Institute, Stockholm (Sweden)

Type 2 diabetes increases the need for pacemaker and implantable cardioverter defibrillator treatment- A Swedish registry report

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Novel aspects of anti bradycardia pacing

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb